Sanara MedTech reported a 19% increase in net revenue to $103.1 million for 2025, driven by strong sales of soft tissue repair products and expanded market penetration. Despite a net loss of $0.4 million from continuing operations, the company improved profitability with adjusted EBITDA rising to $17 million. Sanara reaffirmed its 2026 revenue guidance, expecting 13-17% growth, and plans to invest in R&D and strategic initiatives to support long-term growth in the surgical market. Key product developments include the upcoming U.S. launch of OsStic™ Synthetic Injectable Structural Bio-Adhesive and an Innovative Technology contract for BIASURGE.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
B&M European Value Retail's first-quarter update has divided analysts, with Deutsche Bank upgrading the stock to 'hold' citing stabilizing profit margins and a sensible turnaround strategy by new CEO Tjeerd Jegen. Deutsche Bank raised its profit fore...
AmpliTech Group marked its fifth anniversary as a public company by ringing the Nasdaq opening bell and announcing record revenue of $25.2 million in fiscal 2025, a 165% increase year-over-year. The company, a US-based leader in RF and microwave sign...
Telo Genomics announced positive interim results from a clinical study analyzing blood samples of multiple myeloma patients to predict relapse risk using 3D telomere analysis. The test showed strong predictive accuracy, potentially offering a less in...
Meta now notifies parents if their teen talks about suicide or self-harm with its AI chatbot and is developing a feature to contact emergency services if risk is detected. This move addresses concerns about AI chatbots handling crisis conversations, ...
